CN116676361A - Method for preparing solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues - Google Patents
Method for preparing solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues Download PDFInfo
- Publication number
- CN116676361A CN116676361A CN202310632212.0A CN202310632212A CN116676361A CN 116676361 A CN116676361 A CN 116676361A CN 202310632212 A CN202310632212 A CN 202310632212A CN 116676361 A CN116676361 A CN 116676361A
- Authority
- CN
- China
- Prior art keywords
- ogp
- solution
- osteogenic growth
- solution containing
- growth peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101800003595 Osteogenic growth peptide Proteins 0.000 title claims abstract description 57
- VNTJGCYVIRTGMZ-PXGLAOGESA-N 2-[[2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s,3r)-2-[[(2s)-2-[[2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-oxopentanoyl]amino]acety Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC(C)C)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)NCC(O)=O)C1=CC=C(O)C=C1 VNTJGCYVIRTGMZ-PXGLAOGESA-N 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 33
- 210000004899 c-terminal region Anatomy 0.000 title claims abstract description 18
- 241001465754 Metazoa Species 0.000 title claims abstract description 15
- 230000007515 enzymatic degradation Effects 0.000 title claims abstract description 12
- 235000013372 meat Nutrition 0.000 claims abstract description 6
- 235000013376 functional food Nutrition 0.000 claims abstract description 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 4
- 235000013402 health food Nutrition 0.000 claims abstract 2
- BGFPKYKDLYYTJH-UHFFFAOYSA-N 2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]acetic acid Chemical compound C=1C=CC=CC=1CC(C(=O)NCC(=O)NCC(O)=O)NC(=O)CNC(=O)C(N)CC1=CC=C(O)C=C1 BGFPKYKDLYYTJH-UHFFFAOYSA-N 0.000 claims description 77
- 108010034423 historphin Proteins 0.000 claims description 69
- 239000000243 solution Substances 0.000 claims description 58
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 102000004142 Trypsin Human genes 0.000 claims description 6
- 108090000631 Trypsin Proteins 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000012588 trypsin Substances 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 239000004365 Protease Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 241001550206 Colla Species 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 230000000593 degrading effect Effects 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- 235000019833 protease Nutrition 0.000 claims description 2
- 235000019419 proteases Nutrition 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 229960001322 trypsin Drugs 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 238000001212 derivatisation Methods 0.000 description 43
- 239000012488 sample solution Substances 0.000 description 42
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 36
- 238000005259 measurement Methods 0.000 description 29
- 239000000523 sample Substances 0.000 description 20
- 239000007788 liquid Substances 0.000 description 19
- 108010010803 Gelatin Proteins 0.000 description 17
- 229920000159 gelatin Polymers 0.000 description 17
- 239000008273 gelatin Substances 0.000 description 17
- 235000019322 gelatine Nutrition 0.000 description 17
- 235000011852 gelatine desserts Nutrition 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- 150000002500 ions Chemical class 0.000 description 15
- 239000012086 standard solution Substances 0.000 description 15
- 239000012085 test solution Substances 0.000 description 15
- 235000015278 beef Nutrition 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 239000003292 glue Substances 0.000 description 12
- XQACWEBGSZBLRG-UHFFFAOYSA-N 1-bromo-4-isothiocyanatobenzene Chemical compound BrC1=CC=C(N=C=S)C=C1 XQACWEBGSZBLRG-UHFFFAOYSA-N 0.000 description 11
- 241000270708 Testudinidae Species 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 238000004885 tandem mass spectrometry Methods 0.000 description 10
- 241000282994 Cervidae Species 0.000 description 8
- 235000006439 Lemna minor Nutrition 0.000 description 8
- 241000209501 Spirodela Species 0.000 description 8
- 235000013364 duck meat Nutrition 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 238000007865 diluting Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108090000573 Osteocalcin Proteins 0.000 description 3
- 239000012483 derivatization solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000003394 haemopoietic effect Effects 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 102000004067 Osteocalcin Human genes 0.000 description 2
- 210000003056 antler Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102100031475 Osteocalcin Human genes 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004724 ultra fast liquid chromatography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A method for preparing solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissue, which is a method for obtaining osteogenic growth peptide and C-terminal pentapeptide in meat by enzymolysis, wherein the meat is rich in protein, OGP is obtained by enzymatic degradation, so that a natural source is provided for OGP, and the osteogenic growth peptide can be developed into functional food or health food for more people.
Description
Technical Field
The invention belongs to the technical field of enzymolysis, and particularly relates to a method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues.
Background
Osteogenic growth peptide (osteogenic growth peptide, OGP) is a small molecule polypeptide substance with significant physiological activity. The propeptide consists of fourteen amino acids and has a primary structure of ALKRQGRTLYGFGG. Can promote the expression of cell type I collagen mRNA, osteocalcin (BGP) and alkaline phosphatase (ALpase), so as to increase the cell collagen synthesis, osteocalcin content and alkaline phosphatase activity. Can be clinically used for treating diseases related to bone metabolism unbalance, bone injury, bone marrow transplantation and the like, and can improve the hematopoietic activity of bones and bone marrow, and can be used as a potential application of hematopoietic agonists. The C-terminal pentapeptide OGP (10-14) of the osteogenic growth peptide is the minimum amino acid sequence for keeping the total activity of the propeptide, has obvious proliferation effect on osteoblasts (MC 3T3E 1) and fibroblasts (NIH 3T 3) and also shows obvious osteogenic and hematopoietic activities in animals, and is expected to replace the propeptide to become a new clinical candidate medicament. Although human and animal blood contains osteogenic growth peptides, the content is too small and chemical synthesis is already available in a scale.
Disclosure of Invention
The invention aims to provide a method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues, which is used for obtaining the osteogenic growth peptide and the C-terminal pentapeptide in meat by an enzymolysis mode.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
a method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissue, comprising the steps of:
1. adding 1% NaHCO into proteinase 3 The solution was prepared to contain 1. Mu.g of protease per 1. Mu.L;
2. placing the raw materials into a reaction container, adding a buffer solution with the concentration of 1% -3%, carrying out ultrasonic treatment for 20-40min, shaking up after the volume is fixed by using the buffer solution with the concentration of 1% -3%, filtering by a microporous filter membrane, placing the obtained filtrate into a microscale sample bottle, adding an enzyme solution, shaking up, carrying out enzymolysis at a constant temperature for 10-15 h, and obtaining a solution containing Osteogenic Growth Peptide (OGP) and carbon end pentapeptide OGP (10-14).
Such enzymes include, but are not limited to, pepsin, trypsin, papain, and other enzymes capable of degrading proteins.
The filter membrane is a microporous filter membrane with the thickness of 0.22 mu m.
The buffer solution is NH 4 HCO 3 ,NaHCO 3 ,NH 4 Cl,NaH 2 PO 4 /K 2 HPO 4 One or a mixture of any of the above.
The constant temperature is one of 20-80 ℃.
The solution containing the Osteogenic Growth Peptide (OGP) and the carbon end pentapeptide OGP (10-14) is applied to health-care food or functional food.
The solution containing the Osteogenic Growth Peptide (OGP) and the carbon end pentapeptide OGP (10-14) is applied to cosmetics.
The solution containing the Osteogenic Growth Peptide (OGP) and the carbon end pentapeptide OGP (10-14) is applied to medicines.
The raw materials are meat, animal skin, cornu Cervi Pantotrichum and colla Plastri Testudinis.
The beneficial effects of the invention are as follows:
the meat is rich in protein, and is subjected to enzymatic degradation to obtain OGP, so that a natural source is provided for OGP, and the OGP is obtained from food materials, so that the osteogenic growth peptide can be developed into functional foods or health-care foods for more people.
Drawings
FIG. 1 is an ion chromatogram of the osteogenic growth peptide OGP (10-14) standard and mutton MRM extract of example 1.
FIG. 2 is an ion chromatogram of osteogenic growth peptide OGP (10-14) standard and duck MRM extract of example 2.
FIG. 3 is an ion-extracting chromatogram of the osteogenic growth peptide OGP (10-14) standard and beef MRM in example 3.
FIG. 4 is an ion-extracting chromatogram of osteogenic growth peptide OGP (10-14) standard and beef MRM in example 3.
FIG. 5 is an ion chromatogram of the osteogenic growth peptide OGP (10-14) standard and deer horn gum MRM extract of example 4.
FIG. 6 is an ion chromatogram of the osteogenic growth peptide OGP (10-14) standard and deer horn gum MRM extract of example 4.
FIG. 7 is an ion chromatogram of the osteogenic growth peptide OGP (10-14) standard and tortoise plastron glue MRM extraction in example 5.
FIG. 8 is an ion chromatogram of the osteogenic growth peptide OGP (10-14) standard and tortoise plastron glue MRM extraction in example 5.
FIG. 9 is an ion chromatogram of the osteogenic growth peptide OGP (10-14) standard and donkey-hide gelatin MRM extract of example 6.
FIG. 10 is an ion chromatogram of the osteogenic growth peptide OGP (10-14) standard and donkey-hide gelatin MRM extract of example 6.
FIG. 11 is an ion-extracting chromatogram of the osteogenic growth peptide OGP (10-14) standard and pigskin MRM in example 7.
Detailed Description
The present invention will be further described with reference to the following examples, but the present invention is not limited to the following examples.
Detection of osteogenic growth peptide:
1. experimental instrument:
island UFLC Nexera X2 series ultra-high performance liquid chromatograph (equipped with DGU-20A5R degasser, LC-30AD liquid pump, CBM-20A system controller, SIL-30AC autosampler, CTO-20A column incubator), 8060 triple four-bar tandem mass spectrometer (Shimadzu Corp., japan); island Labsolution Ver.5.93 workstation;
chromatographic column: syncronis HILIC (100 mm. Times.2.1 mm,1.7 μm, thermo Inc. of America)
Milli-Q ultra-pure water machine (Millipore Co., U.S.A.); BT25S electronic balance (precision 0.01mg, sartorius company, germany); KQ-700VDB ultrasonic cleaner (Kunshan ultrasonic instruments Co., ltd.); BI-250A incubator (Shanghai Shi Doukai instruments and equipment Co., ltd.).
2. Experimental materials:
2.1 Standard and control herbs:
the osteogenic growth peptide OGP (10-14) was offered by Shaanxi Huikang Biotechnology Limited liability company.
2.2, reagent:
4-bromophenyl isothiocyanate (purity > 97%, lot C202706, shanghai alading Co., ltd.), trypsin (SEQ ID NO: 0000344639, promega Co., U.S.A.); acetonitrile, methanol (chromatographic grade, merk, germany); formic acid (chromatographic grade, shanghai alading company), ammonium bicarbonate is domestic analytical pure; the water is ultrapure water.
2.3, preparation of standard substance solution:
accurately weighing 1.62mg of osteogenic growth peptide OGP (10-14), placing into a 10mL volumetric flask, adding acetonitrile, dissolving, fixing volume to scale, shaking, and preparing into standard stock solution (concentration of 0.162 mg/mL) of osteogenic growth peptide OGP (10-14) in a refrigerator at 4deg.C.
2.4, preparation of derivatizing reagent:
99.20mg of 4-bromophenyl isothiocyanate is precisely weighed, placed in a 200mL volumetric flask, dissolved by adding acetonitrile, fixed to a scale, and shaken uniformly to obtain a derivative reagent solution (the concentration is 0.48 mg/mL).
Derivatization of series OGP (10-14) standard solutions:
precisely sucking 5mL of OGP (10-14) standard stock solution, placing in a 10mL measuring flask, and diluting with acetonitrile to scale to obtain intermediate stock solution (concentration of 0.081 mg/mL) of OGP (10-14) standard. A serial standard substance solution of OGP (10-14) is prepared by adopting a progressive dilution method, and the derivatization reaction of the OGP (10-14) and the 4-bromophenyl isothiocyanate is carried out according to the volume ratio of 1:1.
Precisely sucking 1mL of OGP (10-14) standard intermediate stock solution 1, placing in a 100mL measuring flask, adding acetonitrile to dilute to a scale, and taking the mixture as No. 7 standard solution (the concentration is 810 ng/mL); precisely sucking 5mL of No. 7 standard solution, placing the solution into a 10mL measuring flask, adding acetonitrile, and diluting to a scale to obtain No. 6 standard solution (with the concentration of 405 ng/mL); precisely sucking 5mL of No. 6 standard solution, placing the solution into a 10mL measuring flask, adding acetonitrile, and diluting to a scale to obtain No. 5 standard solution (the concentration is 202.5 ng/mL); precisely sucking 5mL of No. 5 standard solution, placing the solution into a 10mL measuring flask, adding acetonitrile, and diluting to a scale to obtain No. 4 standard solution (the concentration is 101.25 ng/mL); precisely sucking 4mL of the No. 4 standard solution, placing the solution into a 10mL measuring flask, adding acetonitrile, and diluting to a scale to obtain a No. 3 standard solution (the concentration is 40.5 ng/mL); precisely sucking 5mL of No. 3 standard solution, placing the solution into a 10mL measuring flask, adding acetonitrile, and diluting to a scale to obtain No. 2 standard solution (the concentration is 20.25 ng/mL); 5mL of the No. 2 standard solution was precisely aspirated and placed in a 10mL measuring flask, and acetonitrile was added to dilute to a scale to obtain a No. 1 standard solution (concentration: 10.125 ng/mL).
The derivatization reaction of the OGP (10-14) series standard substance solution and the 4-bromophenyl isothiocyanate is carried out according to the volume ratio of 1:1: precisely sucking 5mL of each of the 1-7 OGP (10-14) serial standard substance solutions, precisely adding 5mL of the derivatization reagent solution respectively, and shaking for 10min to obtain serial standard substance derivatization solutions. The concentrations were 5.06ng/mL, 10.13ng/mL, 20.25ng/mL, 50.63g/mL, 101.25ng/mL, 202.5ng/mL, 405ng/mL, respectively.
Example 1
Taking mutton as an example:
preparation of trypsin solution: adding 1% NH into sequence analysis grade trypsin 4 HCO 3 The solution was prepared to contain 1. Mu.g of solution per 1. Mu.L, which was prepared immediately before use.
10g of mutton is weighed, precisely weighed and placed in a 50mL measuring flask. Adding 1% NH 4 HCO 3 40mL of solution, sonicated for 30min with 1% NH 4 HCO 3 The solution is fixed to the scale and shaken up. Filtering with 0.22 μm microporous membrane, collecting 100 μl of the filtrate, placing into microscale sample bottle, adding trypsin solution 10 μl, and shaking. And carrying out enzymolysis at a constant temperature of 37 ℃ for 12 hours to obtain a mutton sample solution.
Derivatization of test solutions:
30 mu L of mutton sample solution is added with 90 mu L of derivatization reagent solution and is shaken for 10min to obtain beef sample derivatization solution.
UHPLC-MS/MS conditions:
chromatographic conditions:
mobile phase a was 0.1% formic acid solution, mobile phase B was acetonitrile, isocratic eluted with 60% B; the flow rate was 0.3 ml.min -1 The method comprises the steps of carrying out a first treatment on the surface of the Column temperature: 30 ℃; sample injection amount: 2. Mu.L.
Mass spectrometry conditions:
ESI negative ion detection and multi-reaction monitoring mode (MRM) measurement are adopted, and main mass spectrum parameters are as follows: ion source temperature 300 ℃; desolventizing tube temperature: 250 ℃; heating block temperature: 400 ℃; atomized air flow rate was 3.0 L.min -1 The method comprises the steps of carrying out a first treatment on the surface of the Dry air flow: 10.0L min -1 The method comprises the steps of carrying out a first treatment on the surface of the Heating air flow: 10.0L min -1 The method comprises the steps of carrying out a first treatment on the surface of the Collision gas: argon gas.
Table 1 mass spectral parameters of two compounds
Note that is a quantitative ion pair
Preparation of derivative standard curve:
serial standard substance derivatization solutions with 7 different concentrations in derivatization of serial OGP (10-14) standard substance solutions are measured according to the method of the OGP (10-14) derivatization products in UHPLC-MS/MS conditions, each sample is subjected to parallel sample injection measurement for 2 times, and the peak area of the serial standard substance derivatization solutions is recorded. And (3) carrying out linear regression by taking the standard substance concentration as an abscissa and taking the average peak area measured for 2 times as an ordinate, and calculating a regression equation and a correlation coefficient of a standard curve.
Determination of the detection Limit (LOD) and the quantification Limit (LOQ):
continuously diluting and sampling the standard substance derivatization solution, wherein when the signal to noise ratio is more than or equal to 3 (S/N is not less than 3), the concentration of the corresponding OGP (10-14) is the lowest detection limit; when the signal-to-noise ratio is more than or equal to 10 (S/N is equal to or greater than 10), the concentration of the corresponding OGP (10-14) is the quantitative limit. Determination of 3.7.3 precision, stability, reproducibility and recovery:
measuring an OGP (10-14) derivative solution with the concentration of 5.06ng/mL by an injection liquid mass spectrometer, continuously and repeatedly sampling for 6 times, recording the corresponding peak area and retention time, and respectively calculating the relative standard deviation RSD (n=6) of the peak area and retention time, namely the daily sampling precision; the measurement was continuously performed for 3 days, sampling was repeated 6 times per day, the corresponding peak area and retention time were recorded, and the relative standard deviation RSD% (n=18) of the peak area and retention time was calculated, which is the daytime precision.
OGP (10-14) derivatization solutions at a concentration of 101.25ng/mL were injected into a UHPLC-MS/MS instrument for measurement at 0 hours, 2 hours, 4 hours, 8 hours, 12 hours, 16 hours, 20 hours, 24 hours, respectively, corresponding peak areas were recorded, and the relative standard deviation RSD of the peak areas was calculated to examine the stability of the derivatization products under the same analytical measurement conditions.
Taking the reference medicinal materials of the mutton sample solution after enzymolysis, preparing 6 parts of sample solutions after the derivatization of the mutton in parallel according to the derivatization method of the sample solutions, and respectively injecting each part of sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was assayed 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) derivative was calculated, and the relative standard deviation RSD was calculated for evaluating the reproducibility of the samples after derivatization.
Taking 3 parts of the enzymatic hydrolysate of mutton, adding 20 mu L of OGP (10-14) standard substance solution with the concentration of 50.6ng/mL into each 20 mu L of the enzymatic hydrolysate of mutton, adding 40 mu L of a derivative reagent into each 20 mu L of the enzymatic hydrolysate of mutton, and shaking for 10min. All samples were injected into a UHPLC-MS/MS instrument for measurement, the corresponding peak areas were recorded, the content thereof was measured, and the recovery rate of the added samples and the relative standard deviation RSD% were calculated for each sample.
2 parts of sample solution is prepared in parallel by mutton, and 4-bromophenyl isothiocyanate is respectively added for derivatization. And (5) injecting each derived gum sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was measured 2 times in parallel, the corresponding peak area was recorded, and the content of OGP (10-14) was calculated, and the MRM extract ion chromatograms of OGP (10-14) standards and samples were shown in fig. 1. The results of the sample measurements are shown in Table 2.
TABLE 2 OGP (10-14) content in mutton
As is clear from Table 2, OGP (10-14) was detected in mutton.
Example 2
Taking duck meat as an example, preparing a duck meat test solution and a derivatization test solution by the same method, detecting in the same way, taking an enzymolysis duck meat reference medicinal material, taking 3 parts of enzymolysis liquid of the enzymolysis duck meat, adding 20 mu L of OGP (10-14) standard solution with the concentration of 50.6ng/mL into each 20 mu L of enzymolysis liquid of the enzymolysis duck meat, adding 40 mu L of derivatization reagent into each 20 mu L of enzymolysis liquid, and shaking for 10min. All samples were injected into a UHPLC-MS/MS instrument for measurement, the corresponding peak areas were recorded, the content thereof was measured, and the recovery rate of the added samples and the relative standard deviation RSD% were calculated for each sample. 2 parts of sample solution is prepared in parallel from duck meat, and 4-bromophenyl isothiocyanate is respectively added for derivatization. And (5) injecting each derived gum sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was assayed 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) was calculated, the MRM extracted ion chromatograms of OGP (10-14) standard and sample were shown in fig. 2, and the results of the sample assays are shown in table 3.
TABLE 3 OGP (10-14) content in Duck meat
As is clear from Table 3, OGP (10-14) was detected in duck meat.
Example 3
Taking beef as an example, preparing beef sample solution and derivatization sample solution by the same method, detecting in the same way, taking beef reference medicinal materials after enzymolysis, preparing 6 parts of beef sample solution after derivatization in parallel according to the derivatization method of the sample solution, and respectively injecting each part of sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was assayed 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) derivative was calculated, and the relative standard deviation RSD was calculated for evaluating the reproducibility of the samples after derivatization.
Taking 3 parts of beef subjected to enzymolysis, adding 20 mu L of OGP (10-14) standard substance solution with the concentration of 50.6ng/mL into each 20 mu L, adding 40 mu L of derivative reagent into each mu L, and shaking for 10min. All samples were injected into a UHPLC-MS/MS instrument for measurement, the corresponding peak areas were recorded, the content thereof was measured, and the recovery rate of the added samples and the relative standard deviation RSD% were calculated for each sample.
2 parts of test solution are prepared in parallel by beef, and 4-bromophenyl isothiocyanate is respectively added for derivatization. And (5) injecting each derived beef sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was measured 2 times in parallel, the corresponding peak area was recorded, and the content of OGP (10-14) was calculated, and the MRM extract ion chromatograms of OGP (10-14) standard and beef sample were shown in fig. 3 and 4. The results of the sample measurements are shown in Table 4.
TABLE 4 OGP (10-14) content in beef
Example 4
Taking deer horn glue as an example: and (3) preparing a deer-horn glue test solution and a derivatization test solution by the method, detecting in the same manner, taking an enzymolysis deer-horn glue reference medicinal material, preparing 6 parts of deer-horn glue derivatized test solution in parallel according to the derivatization method of the test solution, and respectively injecting each part of test solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was assayed 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) derivative was calculated, and the relative standard deviation RSD was calculated for evaluating the reproducibility of the samples after derivatization.
Taking 3 parts of the deer-horn glue after enzymolysis, adding 20 mu L of OGP (10-14) standard substance solution with the concentration of 50.6ng/mL into each 20uL, adding 40 mu L of derivative reagent into each mu L, and shaking for 10min. All samples were injected into a UHPLC-MS/MS instrument for measurement, the corresponding peak areas were recorded, the content thereof was measured, and the recovery rate of the added samples and the relative standard deviation RSD% were calculated for each sample.
Preparing 2 parts of sample solution in parallel from deer antler glue, and respectively adding 4-bromophenyl isothiocyanate for derivatization. And (5) injecting each part of the derived deer horn gum sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was measured 2 times in parallel, the corresponding peak area was recorded, and the content of OGP (10-14) was calculated, and the MRM extract ion chromatograms of OGP (10-14) standard and deer horn gum samples were shown in fig. 5 and 6. The results of the sample measurements are shown in Table 5.
TABLE 5 OGP (10-14) content in deer antler glue
As is clear from Table 5, OGP (10-14) was detected in deer horn glue.
Example 5
Taking tortoise plastron as an example: and preparing a tortoise plastron solution to be tested and a derivatization solution to be tested by the method, detecting in the same manner, taking a tortoise plastron reference medicinal material after enzymolysis, preparing 6 tortoise plastron solution to be tested after derivatization in parallel according to the derivatization method of the solution to be tested, and respectively injecting each solution to be tested into a liquid chromatograph to be tested. Each sample solution was assayed 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) derivative was calculated, and the relative standard deviation RSD was calculated for evaluating the reproducibility of the samples after derivatization.
Taking 3 parts of tortoise plastron after enzymolysis, adding 20 mu L of OGP (10-14) standard substance solution with the concentration of 50.6ng/mL into each 20 mu L, adding 40 mu L of derivative reagent into each mu L, and shaking for 10min. All samples were injected into a UHPLC-MS/MS instrument for measurement, the corresponding peak areas were recorded, the content thereof was measured, and the recovery rate of the added samples and the relative standard deviation RSD% were calculated for each sample.
2 parts of sample solution is prepared by parallel preparation of tortoise plastron, and 4-bromophenyl isothiocyanate is respectively added for derivatization. And (5) injecting each derived tortoise plastron sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was measured 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) was calculated, and the MRM extracted ion chromatograms of OGP (10-14) standard and tortoise plastron samples were shown in fig. 7 and 8. The results of the sample measurements are shown in Table 6.
TABLE 6 OGP (10-14) content in tortoise plastron glue
As can be seen from Table 6, OGP (10-14) was detected in tortoise-plastron glue.
Example 6
Taking donkey-hide gelatin as an example, preparing an donkey-hide gelatin sample solution and a derivatization sample solution by the same method, detecting the donkey-hide gelatin sample solution in the same manner, performing derivatization on 6 parts of donkey-hide gelatin sample solution in parallel according to the derivatization method of the sample solution, and respectively injecting each part of donkey-hide gelatin sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was assayed 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) derivative was calculated, and the relative standard deviation RSD was calculated for evaluating the reproducibility of the samples after derivatization.
Taking 3 parts of the donkey-hide gelatin control medicinal material after enzymolysis, adding 20 mu L of OGP (10-14) standard substance solution with the concentration of 50.6ng/mL into each 20 mu L, adding 40 mu L of derivative reagent into each mu L, and shaking for 10min. All samples were injected into a UHPLC-MS/MS instrument for measurement, the corresponding peak areas were recorded, the content thereof was measured, and the recovery rate of the added samples and the relative standard deviation RSD% were calculated for each sample. 2 parts of donkey-hide gelatin are prepared in parallel into test solution, and 4-bromophenyl isothiocyanate is respectively added for derivatization. And (5) injecting each derived gum sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was measured 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) was calculated, the MRM extraction ion chromatograms of OGP (10-14) standard and donkey-hide gelatin samples were shown in fig. 9 and 10, and samples of yellow gelatin and new donkey-hide gelatin were prepared, and the measurement results of the samples were shown in table 7.
TABLE 7 OGP (10-14) content in donkey-hide gelatin
As is clear from Table 7, OGP (10-14) was detected in donkey-hide gelatin. OGP was not detected in yellow gelatin and new donkey-hide gelatin (10-14).
Example 7
Taking pigskin as an example, preparing an Ajiao test solution and a derivatization test solution by the same method, detecting in the same way, performing enzymolysis on the pigskin reference medicinal material, preparing 6 parts of pigskin derivatization test solutions in parallel according to the derivatization method of the test solution, and respectively injecting each part of test solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was assayed 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) derivative was calculated, and the relative standard deviation RSD was calculated for evaluating the reproducibility of the samples after derivatization.
Taking 3 parts of pig skin control medicinal materials after enzymolysis, adding 20 mu L of OGP (10-14) standard substance solution with the concentration of 50.6ng/mL into each 20 mu L, adding 40 mu L of derivative reagent into each mu L, and shaking for 10min. All samples were injected into a UHPLC-MS/MS instrument for measurement, the corresponding peak areas were recorded, the content thereof was measured, and the recovery rate of the added samples and the relative standard deviation RSD% were calculated for each sample. 2 parts of sample solutions are prepared in parallel from pigskin, and 4-bromophenyl isothiocyanate is added for derivatization. And (5) injecting each derived gum sample solution into a liquid chromatograph-mass spectrometer for measurement. Each sample solution was measured 2 times in parallel, the corresponding peak area was recorded, the content of OGP (10-14) was calculated, the MRM extraction ion chromatograms of OGP (10-14) standard and pigskin samples were shown in fig. 11, and samples in yellow gelatin and new pigskin were prepared, and the measurement results of the samples were shown in table 8.
TABLE 8 OGP (10-14) content in pigskin and pork
As is clear from Table 8, OGP (10-14) was detected in pigskin, but not in pork.
Claims (9)
1. A method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissue, comprising the steps of:
1. adding 1% NaHCO into proteinase 3 The solution was prepared to contain 1. Mu.g of protease per 1. Mu.L;
2. placing the raw materials into a reaction container, adding a buffer solution with the concentration of 1% -3%, carrying out ultrasonic treatment for 20-40min, shaking up after the volume is fixed by using the buffer solution with the concentration of 1% -3%, filtering by a microporous filter membrane, placing the obtained filtrate into a microscale sample bottle, adding an enzyme solution, shaking up, carrying out enzymolysis at a constant temperature for 10-15 h, and obtaining a solution containing Osteogenic Growth Peptide (OGP) and carbon end pentapeptide OGP (10-14).
2. The method of claim 1, wherein the enzyme comprises, but is not limited to, pepsin, trypsin, papain and other enzymes capable of degrading proteins.
3. The method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissue according to claim 1, wherein the filter membrane is a microporous filter membrane of 0.22 μm.
4. The method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissue according to claim 1, wherein the buffer solution is NH 4 HCO 3 ,NaHCO 3 ,NH 4 Cl,NaH 2 PO 4 /K 2 HPO 4 One or a mixture of any of the above.
5. The method of claim 1, wherein the constant temperature is one of 20-80 ℃.
6. The method for preparing the solution containing the osteogenic growth peptide and the C-terminal pentapeptide from the enzymatically degraded animal tissue according to claim 1, wherein the solution containing the Osteogenic Growth Peptide (OGP) and the C-terminal pentapeptide OGP (10-14) is applied to health foods or functional foods.
7. The method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide according to claim 1, wherein the solution containing Osteogenic Growth Peptide (OGP) and C-terminal pentapeptide OGP (10-14) is applied in cosmetics.
8. The method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide according to claim 1, wherein the solution containing Osteogenic Growth Peptide (OGP) and carbon-terminal pentapeptide OGP (10-14) is used in pharmaceutical products.
9. The method for preparing a solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissue according to claim 1, wherein the raw material is meat, animal skin, cornu Cervi Pantotrichum, and colla Plastri Testudinis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310632212.0A CN116676361A (en) | 2023-05-31 | 2023-05-31 | Method for preparing solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310632212.0A CN116676361A (en) | 2023-05-31 | 2023-05-31 | Method for preparing solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116676361A true CN116676361A (en) | 2023-09-01 |
Family
ID=87790186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310632212.0A Pending CN116676361A (en) | 2023-05-31 | 2023-05-31 | Method for preparing solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116676361A (en) |
-
2023
- 2023-05-31 CN CN202310632212.0A patent/CN116676361A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Min et al. | Determination of dl-amino acids, derivatized with R (−)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N, N-dimethylaminosulfonyl)-2, 1, 3-benzoxadiazole, in nail of diabetic patients by UPLC–ESI-TOF-MS | |
CN101273267B (en) | Method for analysis of albumin in sample solution | |
CN113009026B (en) | Elution gradient method for measuring glycosylated hemoglobin in whole blood | |
EP2047279B1 (en) | A reagent for digestion of hemoglobin | |
CN110018266A (en) | A kind of method of 48 kinds of amino acid of fast quantitative analysis | |
JP4563764B2 (en) | Peptide quantification method | |
CN103837620A (en) | Method for simultaneously detecting content of multiple amino acids in plasma of human body | |
CN108948176B (en) | Osteopontin characteristic peptide and application thereof | |
CN111579685A (en) | Kit for detecting anticoagulant drugs in blood plasma and application thereof | |
CN113533565A (en) | Method for detecting concentrations of 8 flavonoid compounds in human urine by UPLC-MS/MS method | |
CN110702805B (en) | UPLC-MSMS detection method for establishing 19 sulfanilamide residues in cultured fish based on ASE method of C18 | |
CN106596771B (en) | A method of beta-hydroxy-Beta-methyl butyric acid content in measurement soybean peptide protein powder | |
Loewy | The Nε-(γ-glutamic) lysine cross-link: Method of analysis, occurrence in extracellular and cellular proteins | |
Lewis et al. | Whole-blood and plasma amino acid analysis: gas-liquid and cation-exchange chromatography compared. | |
CN113917007A (en) | Kit for detecting human urine catecholamine and intermediate metabolites thereof and test method | |
CN116676361A (en) | Method for preparing solution containing osteogenic growth peptide and C-terminal pentapeptide by enzymatic degradation of animal tissues | |
CN107976499A (en) | A kind of method of alpha-aminobutyric acid content in efficiently binary liquid chromatography detection livestock and poultry organization | |
Morgan et al. | The compositions and quantitative relations of protein and related fractions in developing root cells | |
Byrd et al. | Direct determination of cotinine‐N‐glucuronide in urine using thermospray liquid chromatography/mass spectrometry | |
CN114137105B (en) | Method for analyzing melatonin content in sample by liquid chromatography-tandem mass spectrometry | |
CN114414679B (en) | Method for detecting belladonna alkaloid in animal tissues | |
Lange et al. | Fast method for the simultaneous determination of 2-oxo acids in biological fluids by high-performance liquid chromatography | |
Paroni et al. | Total urinary hydroxyproline determined with rapid and simple high-performance liquid chromatography | |
CN113588826A (en) | Method for simultaneously detecting forty-eight stimulants in animal body fluid | |
McGregor et al. | Determination of urinary amino acids by gas chromatography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |